RNF43: A Biomarker With Potential Ramifications for Therapeutic Intervention in Gastric Cancer

Cell Mol Gastroenterol Hepatol. 2021;11(4):1202-1203. doi: 10.1016/j.jcmgh.2020.11.014. Epub 2020 Dec 19.

Authors

Jennifer M Noto¹, Richard M Peek Jr²

Affiliations

¹ Division of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
² Division of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Electronic address: richard.peek@vumc.org.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Biomarkers
Carcinogenesis
Humans
Stomach Neoplasms* / therapy
Ubiquitin-Protein Ligases
Wnt Signaling Pathway

Substances

Biomarkers
RNF43 protein, human
Ubiquitin-Protein Ligases

Grants and funding